Trial intelligence / Profile preview

Remimazolam vs Propofol for Hemodynamic Stability in Endovascular Aortic Repair

NCT07806006Phase 4Recruiting

Sponsor
Seoul National University Hospital
Start
Oct 2026
Primary completion
Sep 2027
Countries
1
01

Overview

A Phase 4 trial of remimazolam in intraoperative hypotension (IOH), hemodynamic instability, sponsored by Seoul National University Hospital. Started Oct 2026; status: recruiting.

02

Drugs

remimazolam
03

Conditions

intraoperative hypotension (IOH)hemodynamic instability

Beyond the preview

Go deeper on NCT07806006.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07806006.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call